iMeds.se

Donepezil Sandoz

Information för alternativet: Donepezil Sandoz 5 Mg Munsönderfallande Tablett, Donepezil Sandoz 10 Mg Munsönderfallande Tablett, visar 2 alternativ
Document: Donepezil Sandoz orodispersible tablet ENG PL change

Package leaflet: Information for the user


Donepezil Sandoz 5 mg orodispersible tablets

Donepezil Sandoz 10 mg orodispersible tablets


donepezil hydrochloride


Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.


What is In this leaflet:

1. What Donepezil Sandozis and what it is used for

2. What you need to know before you take Donepezil Sandoz

3. How to take Donepezil Sandoz

4. Possible side effects

5. How to store Donepezil Sandoz

6. Contents of the pack and other information


1. What Donepezil Sandoz is and what it is used for

Donepezil Sandoz belongs to a group of medicines called acetylcholinesterase inhibitors. Donepezil increases the levels of a substance (acetylcholine) in the brain involved in memory function by slowing down the breakdown of acetylcholine.

Donepezil Sandoz is used to treat the symptoms of dementiain people diagnosed as having mild to moderately severeAlzheimer’s Disease. The symptoms include increasing memory loss, confusion and behavioural changes. As a result, sufferers of Alzheimer’s disease find it more and more difficult to carry out their normal daily activities

Donepezil Sandoz is for use in adult patients only.


2. What you need to know before you takeDonepezil Sandoz


Do not take Donepezil Sandoz

if you are allergic to

Warnings and precautions


Talk to your doctor, pharmacist or nurse before taking Donepezil Sandoz. If any of the following concerns you, you or your caregiver should inform your doctor or pharmacist.


Also tell your doctor if you are pregnant or think you might be

Other medicines and Donepezil Sandoz


Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.

This includes medicines that your doctor has not prescribed for you but which you have bought yourself from a chemist/pharmacist. It also applies to medicines you may take sometime in the future if you continue to take Donepezil Sandoz. This is because these medicines may weaken or strengthen the effects of Donepezil Sandoz

Especially tell your doctor if you are taking any of the following types of medicines:


If you are going to have an operation that requires you to have a general anaesthetic, you should tell your doctor and the anaesthetist that you are taking Donepezil Sandoz. This is because your medicine may affect the amount of anaesthetic needed.

Donepezil Sandoz can be used in patients with kidney disease or mild to moderate liver disease. Tell your doctor first if you have kidney or liver disease. Patients with severe liver disease should not take Donepezil Sandoz.


Tell your doctor or pharmacist the name of your caregiver. Your caregiver will help you to take your medicine as it is prescribed.


Donepezil Sandoz with food, drink and alkohol


Food will not influence the effect of Donepezil Sandoz.


Donepezil Sandoz should not be taken with alcohol because alcohol may change its effect.


Pregnancy, breast-feeding and fertility



Driving and using machines

Alzheimer’s disease may impair your ability to drive or operate machines.Do not perform these activities unless your doctor has confirmed that this is safe.

This medicine can cause fatigue, dizziness and muscle cramps particularly during the beginning of therapy and dose increase. If affected you must not drive or operate machines.



Donepezil Sandoz contains aspartame

Which is a source of phenylalanine. May be harmful for people with phenylketonuria.


3. How to take Donepezil Sandoz


Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure. The usual dose is:


Adults and elderly patients

<for 5 mg tablets>


<for 10 mg tablets>


Do not alter the dose yourself without your doctor’s advice.


Patients with kidney dysfunction

You can take the usual dose as described above. No adjustment is required.


Patients with mild to moderate liver dysfunction

Your doctor will check your tolerance to Donepezil Sandoz before increasing the dose.


Patients with severe liver dysfunction

Your doctor will decide if Donepezil Sandoz is suitable for you.Patients with severe liver disease should not take Donepezil.


Method of administration

Take your orodispersible tablets at night before you go to bed, independently from meals. Place them on your tongue and let them disintegrate before swollowing, with or without water, according to your preference.


Duration of use

Your doctor or pharmacist will advise you on how long you should continue to take your tablets. You will need to see your doctor from time to time to review your treatment and assess your symptoms.


If you take more Donepezil Sandoz than you should DO NOT take more than 10 mg Donepezil hydrochloride each day.

Call your doctor immediately if you take more than you should. If you cannot contact your doctor, contact the local hospital Accident and Emergency department at once. Always take the orodispersible tablets, this leaflet and/or the carton with you to the hospital so that the doctor knows what has been taken.

Symptoms of overdosing include feeling and being sick, drooling, sweating, slow heart rate, low blood pressure (light-headedness or dizziness when standing), breathing problems, losing consciousness and seizures (fits) or convulsions.


If you forget to take Donepezil Sandoz

If you forget to take an orodispersible tablet, just take one orodispersible tablet the following day at the usual time. Do not take a double dose to make up for a forgotten dose.

If you forget to take your medicine for more than one week, call your doctor before taking any more medicine.


If you stop taking Donepezil Sandoz

Do not stop taking the orodispersible tablets unless instructed by your doctor. Positive treatment results may gradually diminish if treatment is stopped.


If you have any further questions on the use of this medicine, ask your doctor or pharmacist.


4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Serious side effects:


You must tell your doctor immediately if you notice these serious side effects mentioned.You may need urgent medical treatment.


liver damage e.g. hepatitis. The symptoms of hepatitis are feeling or being sick, loss of appetite, feeling generally unwell, fever, itching, yellowing of the skin and eyes, and dark coloured urine (may affect up to 1 in 1,000 people)

Stomach or duodenal ulcers. The symptoms of ulcers are stomach pain and discomfort (indigestion) felt between the navel and the breast bone (may affect up to 1 in 100 people)

bleeding in the stomach or intestines. This may cause you to pass black tar like stools or visible blood from the rectum (may affect up to 1 in 100 people).

seizures (fits) or convulsions (may affect up to 1 in 100 people).

fever with muscle stiffness, sweating or a lowered level of consciousness, These are the symptoms of a disorder called “Neuroleptic Malignant Syndrome” (may affect up to 1 in 10,000 people)

Muscle weakness, tenderness or pain and particularly, if at the same time, you feel unwell, have a high temperature or have dark urine. They may be caused by an abnormal muscle breakdown which can be life threatening and lead to kidney problems (a condition called rhabdomyolysis) (may affect up to 1 in 10,000 people).


Other side effects that may occur:


Very common,may affect more than 1 in 10 people:



Common,may affect up to 1 in 10 people


Uncommon,may affect up to 1 in 100 people

slow heart beat


Rare,may affect up to 1 in 1,000 people:


Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse.This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V*.

By reporting side effects you can help provide more information on the safety of this medicine.



5. How to storeDonepezil Sandoz


Keep out of the sight and reach of children.


Do not use this medicine after the expiry date which is stated on the carton and blister or on the label of the plastic-bottle after “Exp”. The expiry date refers to the last day of that month.


Do not store above 25°C.


Do not use this medicine after 6 months have elapsed from first opening of the plastic-bottle.


Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.


6. Contents of the pack and other information


What Donepezil Sandoz contains

The active substance is donepezil hydrochloride.

5 mg: Each orodispersible tablet contains 5 mg of donepezil hydrochloride.

10 mg: Each orodispersible tablet contains 10 mg of donepezil hydrochloride.


The other ingredients are:

<5 mg:>

Aspartame (E 951)

Croscarmellose sodium

Magnesium stearate

Mannitol (E 421)

Microcrystalline cellulose

Peppermint flavour

Silica, colloidal anhydrous

Zinc sulfate monohydrate


<10 mg:>

Aspartame (E 951)

Croscarmellose sodium

Iron oxide yellow (E 172).

Magnesium stearate

Mannitol (E 421)

Microcrystalline cellulose

Peppermint flavour

Silica, colloidal anhydrous

Zinc sulfate monohydrate


What Donepezil Sandoz looks like and contents of the pack

Donepezil Sandoz are white, round, flat with embossment “5” on one side and plain on the other side.


Donepezil Sandoz are yellow, slightly dotted, round, flat with embossment “10” on one side and plain on the other side.


Donepezil Sandoz is available in


Not all pack sizes may be marketed.


Marketing Authorisation Holder and Manufacturer

Marketing Authorisation Holder

<To be completed nationally>


Manufacturer

<To be completed nationally>


This medicinal product is authorised in the Member States of the EEA under the following names:

<To be completed nationally>


This leaflet was last revised in2015-12-18